life science investing Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology Annual Meeting
life science investing Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial OfficerÂ